NovoMatrix®
Reconstructive Tissue Matrix – the next generation material
NovoMatrix™ is an acellular dermal matrix derived from porcine tissue. In surgical application, the tear-resistant and easy-to-handle1, 2 matrix is an excellent alternative to autologous connective tissue grafts (CTG). There is no need for an intraoral surgical donor site, which reduces morbidity for the patient.
Owing to the manufacturing process, the matrix is free of donor cells. At the same time, the structure of the source tissue remains virtually unchanged, thus supporting the ingrowth of cells and micro-vessels. Proprietary tissue processing enables optimal cell repopulation and revascularization through gentle preparation, resulting in esthetic soft tissue regeneration3. NovoMatrix is supplied pre-hydrated in a patented aqueous phosphate-buffered solution containing matrix stabilizers and can therefore be used promptly without requiring extensive rehydration4.
Upon transplantation, NovoMatrix is repopulated by the patient’s cells and turns into functional soft tissues within three months.
To learn more about NovoMatrix, please contact your distribution partner here.
References
[1] Data on file, Allergan. NovoMatrix™ – Mechanical testing, Preclinical Data.
[2] Data on file, Allergan. INT/0204/2018.
[3] Suárez-López Del Amo F, Rodriguez JC, Asa‘ad F, Wang HL. Comparison of two soft tissue substitutes for the treatment of gingival recession defects: an animal histological study. J Appl Oral Sci., 2019;27:e20180584.
[4] Reference manufacturer’s Instructions for Use (IFU) package insert.